(Q80397425)
Statements
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years (English)
Stephen R Durham
Ronald Dahl
Alexander Kapp
Giselda Colombo
Jan G R de Monchy
Sabina Rak
Waltraud Emminger
Bente Riis
Pernille M Grønager
26 December 2007